Consider a 3-state system with one absorbing state, such as Healthy, Sick, and Dead. Over time, the prevalence of the Healthy state will approach an 'equilibrium' value that is independent of the initial conditions. We derived this equilibrium prevalence (Prev:Equil) as a function of the local transition probabilities. We then used Prev:Equil to estimate the expected number of years spent in the healthy state over time. This estimate is similar to the one calculated by multi-state life table methods, and has the advantage of having an associated standard error. In longitudinal data for older adults, the standard error was accurate when a valid survival table was known from other sources, or when the available data set was sufficient to estimate survival accurately. Performance was better with fewer waves of data. If validated in other situations, these estimates of prevalence and years of healthy life (YHL) and their standard errors may be useful when the goal is to compare YHL for different populations.
INTRODUCTION
The health of the public may be represented as a 3-state system in which persons can be Healthy, Sick, or (eventually) Dead. The transition probabilities among states at different ages may be Figure 1 shows the possible transitions among three states of health. Persons who are Healthy have the probability P(H |H ) of being Healthy 1 year later, P(S|H ) of being Sick 1 year later, and P(D|H ) of being dead 1 year later. Similarly, persons who are Sick have the associated probabilities P(H |S), P(S|S), and P(D|S). For this paper we used longitudinal data on selfreported health status, defining Healthy as being in excellent, very good, or good health, and Sick as being in fair or poor health. (Other definitions could have been used.) The age-specific probabilities of transition among the three states were estimated from about 40 000 transition pairs (two measures for the same person 1 year apart) from the CHS, as described in Section 5.1. The probabilities for age 65 are shown in Figure 1 .
The transition probabilities can be used to estimate the number of persons who will be in each state at each age, for given initial conditions. Consider an initial population of 65-year-olds of whom 80 000 are healthy and 20 000 are sick. The transition probabilities in Figure 1 indicate that at age 66, 12 per cent of the healthy would have become sick (9600) and 2 per cent would have died (1600) while 27 per cent of the sick would have become healthy (5400). The number expected to be healthy at age 66 is thus 80 000−9600−1600+5400 = 73 640. Similarly, the expected number sick and dead at age 66 will be 22 400 and 3200, respectively. The number in each state at age 67 can be calculated in the same way, but using the transition probabilities for age 66-67, which are slightly different from those in Figure 1 because transition probabilities change with age [7] . The MSLT calculations were implemented on a spreadsheet for this paper. They could alternatively have been calculated as a product of stochastic matrices multiplied by a vector of initial conditions or using an on-line Stata program [8] .
If this system satisfied the one-step Markov properties, knowledge of a person's state at a particular age would completely determine his transition probabilities; that is, all persons in a given state would have the same transition probabilities. That is not the case here. For example, healthy 70-year-olds who were also healthy at age 69 have a probability of 0.91 of being healthy at age 71, compared with a probability of 0.61 for those who were sick at age 69 and healthy at age 70 (data not shown). However, the MSLT calculations are based on the population-average transition probability for each age-specific state, sometimes known as the cohort (rather than the individual) probability [9] . The average transition probability can be estimated from population data without knowledge of the individual probabilities. For example, suppose the Healthy state at age 70 comprised 2 sub-states of the same size, one with a probability of 0.9 of being healthy the following year and one with a probability of 0.7 of being healthy. The average transition probability is 0.8, and indeed, 80 per cent are expected to remain healthy at age 71 (90 per cent of group 1 and 70 per cent of group 2), even though no person in the population had a transition probability of 0.8. The average transition probability is thus sufficient for this calculation. At age 71, there will no longer be two equal subgroups, but the average transition probabilities may be estimated from a random sample of 71-year-olds. The CHS population, described in Section 5, was positively selected at baseline. However, most of the data used to estimate the transition probabilities were collected long after baseline, when the sample should have been at equilibrium. The life expectancy calculated from CHS data is reasonably close to national estimates, suggesting that the estimates are valid [10] . Figure 2 shows the projected prevalence of the Healthy state, calculated for a hypothetical cohort in which all of the 100 000 persons were Healthy at age 65 (solid line), for a second cohort where 80 000 were healthy and 20 000 were sick at age 65 (dotted line), and for a third cohort where the 100 000 persons were Sick at birth (dashed line). Note that after a few years the prevalence is virtually independent of the starting conditions. We will refer to this as the 'equilibrium' prevalence (Prev:Equil) at a particular age.
ESTIMATING THE PREVALENCE OF THE HEALTHY STATE
When longitudinal data are available, the obvious or 'natural' prevalence estimate (Prev:Nat) at, say, age 75 would be to collect all persons who were age 75 at any survey wave, and calculate the proportion who were healthy. Prev:Nat is a proportion, and its variance is clear. Alternatively, the prevalence may be taken directly from the MSLT (Prev:MSLT), but the variance of Prev:MSLT is not known. As a third approach, we next derive an estimate of the equilibrium prevalence (Prev:Equil) seen in Figure 2 , under three different assumptions about the transition probabilities. For notational convenience we will estimate 'K ', the number who are healthy divided by the number who are sick. The prevalence is then K /(1+ K ).
Time-homogeneous probabilities with no deaths
In Figure 1 , first assume that the probabilities are the same for everyone in the state and do not change over time (are time homogeneous), and that the probability of death is negligible or zero. This leaves two states, Healthy and Sick, which are persistent (reachable from either state) and aperiodic (can be reached in one or more steps), which is the definition of an 'ergodic' state. When all states are ergodic, the associated Markov chain is also ergodic, and will converge to a limiting distribution independent of the initial state distribution [11] . This limiting distribution can be determined by inspection. 
Time-homogeneous probabilities and non-negligible death rates
Next, assume that the probabilities are time homogeneous, but the probability of dying is not negligible. Because death is an absorbing state, the process is no longer ergodic, and we drop the Markov assumption from here on. As shown in Figure 2 , there is a limiting ratio of the number healthy to the number sick. We solved for the constant, K , such that, for some t,
As shown in Appendix A,
That is, no matter what the initial conditions, H t /S t will converge to K . Equation (2) reduces to equation (1) if the probability of death is negligible. From the probabilities in Figure 1 , K = 2.67; that is, after a few years to overcome any imbalance caused by the initial conditions, there will always be approximately 2.67 times as many Healthy as Sick persons, until eventually all are dead. Prev: Equil = 2.67/(1+2.67) = 0.73.
Time-inhomogeneous probabilities and non-negligible death rates
Transition probabilities do change with age, as older adults are more likely than younger persons to get sick or die [6, 7] . If, however, the probabilities do not change very rapidly, the relevant equilibrium could have been approximately reached at each age, and equation (2) may hold approximately. This seems to be the case, as shown in the first two columns of Table I , where Prev:MSLT and Prev:Equil are very similar (this example is explained below).
Variance of prevalence estimates
The variance of Prev:Nat is Prev: Nat * (1−Prev: Nat)/n and the variance of Prev:MSLT is unknown. We approximated the variance of Prev:Equil by the delta method, as shown in Appendix B.
YEARS OF HEALTHY LIFE
YHL is the projected number of years that a population with a specified initial distribution will spend in the healthy state. This is a standard output of MSLT calculations. A different estimate of YHL combines a national life table with cross-sectional health data and is known as the 'Sullivan method' [12] . If the proportion of the life table cohort still alive at age t is A t , then life expectancy = A t . (The first and last terms should be divided by 2, to agree with the trapezoidal Columns 1-3 are the age-specific prevalences, estimated as noted in the column heading. Prev:MSLT is calculated from the multi-state life table; Prev:Equil is calculated using the equilibrium ratio; and Prev:Nat is the proportion of persons at each age who are healthy, combining all waves of data. Columns 4, 5, and 7 are standard deviations of the prevalence in 1000 bootstrap samples. Column 6 is the mean s.e. calculated from Appendix B equations. Column 8 is the mean s.e. calculated as Prev : Nat * (1−prevalence)/n. method for estimating the area under the curve, but we omit this for simplicity.) YHL is calculated as
where Prev t is the estimated prevalence at age t. If A t is known without error, and the prevalence estimate at one age is independent of the prevalence estimates at other ages, the estimate of YHL is merely the weighted sum of independent prevalences and its variance is
Under stationarity assumptions, the estimate of YHL is unbiased and consistent, and the variance estimator is consistent and approximately unbiased [12] . Prevalence estimates calculated from longitudinal (rather than cross-sectional) data are likely to be correlated across ages, however, because the same person contributes data at different ages (up to 10 times in the example data). Prev:MSLT at, say, age 75 is calculated from all of the transition data up to age 75, and also depends on the initial conditions. Prev:Equil depends on the transition data from age 74-75. Prev:Nat depends only on the data at age 75. It seems likely that estimates of Prev:MSLT at various ages would be highly correlated, and that this would also be true for Prev:Nat. The patterns of correlations for Prev:Equil are not immediately obvious and are explored below.
EXAMPLE
We used longitudinal data from the CHS to compare the prevalence and the YHL estimates. We constructed 1000 bootstrap samples to help evaluate the various estimates and their standard errors.
Data
The CHS is a population-based longitudinal study of 5888 adults aged 65 and older at baseline, designed to identify factors related to the occurrence of coronary heart disease and stroke [13] . Subjects were recruited from a random sample of the Medicare eligibility lists in four U.S. counties. Persons not expected to be able to participate for 3 years, or who were institutionalized, using a wheelchair at home, or under treatment for cancer at baseline were ineligible, and about 59 per cent of those eligible agreed to enroll [14] . Two cohorts were followed, one with 10 annual waves of data (n = 5201) and the second (all African American, n = 687) with seven waves. Linear interpolation was used to impute missing data when values were known for interviews before and after the missing value. With this approach, data completeness increased from about 93 to 95 per cent. At baseline the mean age was 73 years (range of 65-100), 58 per cent were women, and 84 per cent were white. Data collection began in about 1990, and follow-up is virtually complete for all surviving subjects in the year 1999. There were 42 453 transition pairs (defined here as two health measures for the same person 1 year apart, where the person is alive in the first year) in the age range of 68-87 years, collected from 5764 persons who were in that age range at some time during the study, or an average of 7.4 transition pairs per person. (In this age range there were at least 200 sick persons at each age, permitting reasonable estimates of the associated transition probabilities.) We created 1000 bootstrap samples by resampling the 5764 persons with replacement, creating transition pairs, then calculating transition probabilities, and finally using the probabilities to calculate various estimates of age-specific prevalence and YHL.
Prevalence estimates and their variances
The first three columns of Table I present the means (from the 1000 bootstrap samples) of the three prevalence estimates under consideration. (The initial conditions for the MSLT calculation were chosen to make Prev : MSLT = Prev : Equil at age 69.) The three estimates agree well, with Prev:MSLT slightly higher than the other two estimates. Columns 4-8 are the standard errors of the prevalence estimates, both the bootstrap and the derived estimates. Among the three bootstrap estimates, the standard error of Prev:Equil (column 5) was about 1.8 times as large as the standard error of Prev:MSLT estimate (column 4) and of Prev:Nat (column 7). The derived standard error of Prev:Equil is very close to the true value (columns 5 and 6), and the derived standard error for Prev:Nat is also appropriate (columns 7 and 8). The derived standard error of Prev:Equil was thus approximately unbiased, but was nearly twice as large as the standard error of the other prevalence estimates. 
Correlations of prevalence estimates over age
The variance of the YHL estimate, in equation (4), assumes that the prevalences at each age are independent. However, they will be correlated when estimated from the longitudinal data, because the same person will contribute data at up to nine different ages. As expected, Prev:MSLT at one age was highly positively correlated with Prev:MSLT at ages up to 9 years away, with correlations as high as 0.75 (correlation matrix not shown). The Prev:Nat correlations were also positive and substantial, with a maximum value of 0.59 (not shown). For example, the correlation between Prev:MSLT at ages 75 and 76 was 0.53, and the corresponding correlation for Prev:Nat was 0.48. Table II shows the sample correlation coefficients among the Prev:Equil estimates at different ages, which have an unexpected pattern. They are relatively low, and many are negative. The correlation of Prev:Equil at ages 75 and 76 is negative (−0.1169), and in general the prevalence estimates at ages t +1 and t −1 are negatively correlated with the prevalence estimate at t. Since the correlations are relatively small and some are negative, it is likely that the variance from equation (4) will be more appropriate for Prev:Equil than for Prev:Nat. (3)); column 2 shows the source of the prevalence estimate; column 3 shows how YHL was calculated; then mean YHL, the bootstrap standard error of YHL, and the derived standard error and their ratio are shown. Row 1 shows the results of performing a MSLT calculation on each of the 1000 bootstrap samples. YHL averaged 11.013 years in the healthy state (YHL), with a bootstrap standard deviation of 0.116. Row 2, using the Sullivan method with A t taken from the life table calculated for each bootstrap sample (1000 different life tables), is identical. Row 3, which uses the single life table from the actual data, has a similar mean YHL but a lower standard error. Thus, our data set was not large enough to justify the Sullivan method assumption that the variability of the life table was negligible.
Years of Healthy Life (YHL)
In line 4a we combined each of the 1000 life tables from the MSLT bootstrap with its associated values of Prev:Nat, to estimate YHL using the Sullivan method (equation (3)). Line 4b used the single life table from the available data, and line 4c used the U.S. life table. Lines 5a-c are similar but used Prev:Equil. The bootstrap and Sullivan standard errors for YHL are in columns 5 and 6, and their ratio is in column 7. The Sullivan standard error is much too small in line 4a (only about 32 per cent of the bootstrap standard error) and is still too small in line 4b (about 48 per cent of bootstrap). For Prev:Equil, the standard error was 56 per cent of the bootstrap if 1000 life tables were used and 82 per cent if a single life table was used. The YHL estimate was different when we used the U.S. life table (perhaps because the CHS participants were initially favorably selected), but the standard errors on lines 4c and 5c were comparable with those in lines 4b and 5b, and again the standard errors were underestimated as compared with the bootstrap. The standard error of YHL that used Prev:Equil was better than the one using Prev:Nat, but both were biased low.
CHS had 10 waves of data collection, which is an unusually high number. In surveys with fewer waves, the correlation among the ages should attenuate sooner. For example, if we had used only a single wave of data to estimate the prevalence (Prev:Natural), there would be no correlation and equation (4) waves (0.071). Discarding the follow-up data to eliminate correlation would thus be inefficient.) If there are only two waves, each person contributes a single transition and equation (4) is accurate. If there are three waves, all of the correlations among ages are negative, and equation (4) should be conservative. For four waves, there will be an approximately equal mix of positive and negative correlations, which might balance out. To explore the effect of using fewer than 10 waves we repeated the bootstrap calculations using only five waves of data, which cut the number of transition pairs approximately in half. The last three rows in Table III show the results. The bootstrap standard errors on lines 6a-c are larger than those on 5a-c, because there were half as many transition pairs. However, as expected, the derived standard error of YHL based on Prev:Equil (line 6b) was no longer biased low; it averaged 98 per cent of the bootstrap value. Using fewer waves of data did not improve the estimates on lines 6a (compared with line 5a), apparently because the 1000 life tables were estimated with even less precision in the smaller data set. The bootstrap standard error for the MSLT estimate (Table III , line 1 = 0.116) is about the same as that for the equilibrium estimate (line 5a = 0.112). However, when only five waves were used, the standard error for the MSLT estimate was 0.303 (not shown) versus 0.224 (line 6a). This suggests that when the sample size is not large, the equilibrium estimate may be less variable than the MSLT estimate. It also suggests that it may be unwise to apply the standard error from the equilibrium estimate to the MSLT estimate, although that would be attractive. 
The equilibrium estimate of the prevalence
The pseudo-equilibrium in equation (2) holds for any 3×3 stochastic matrix with one absorbing state (classified as matrix type '6-d' by Chakraborty and Rao) [15] , and may be of theoretical interest in research about this type of matrix. Here, we have concentrated on its practical applications.
Age-specific prevalence
We compared three estimates of age-specific prevalence from longitudinal data. All estimates were similar, but Prev:Equil was more variable than the other two. Because Prev:Equil easily reproduces Prev:MSLT, it might be preferred to actually performing the MSLT calculation if the ultimate goal is to estimate age-specific prevalence. Prev:Equil has an associated variance, which Prev:MSLT does not. Because it is based on transition probabilities rather than on the sample prevalence, and is independent of initial conditions, Prev:Equil may be less biased than Prev:Nat if the data are believed to be biased (for example, in volunteer samples, which are often too healthy at baseline). However, the mean-squared error of the estimate would usually be larger for Prev:Equil than for Prev:Nat. Prev:Equil might be useful in sensitivity analyses when the sample is believed to be biased.
Correlations of prevalence estimates at different ages
The negative correlation between Prev:Equil at t with that at t +1 and t −1 was not expected. This apparently occurred because persons who make transitions in a given year (say, from healthy to sick) contribute to the estimate of the transition probabilities conditional on being healthy in the first year, and to the probabilities conditional on being sick in the following year. In a younger population that had lower probabilities of transition, this correlation pattern might be different. This interesting correlation structure could benefit from further exploration.
Years of Healthy Life
The YHL estimates based on Prev:Equil and using the Sullivan method were close to the MSLT estimates. The derived standard error of YHL based on Prev:Equil was close to the bootstrap estimate when only a single life table was used (that is, when there was no variability in the life table). It should perform better, and may even be conservative (because of the negative correlations), when the number of waves of data is not large (here, five or fewer). The assumption that variation in the life table is negligible is usually not verifiable. If it makes sense for the scientific question, the problem can be resolved by using national life tables. If, however, the goal is to compare YHL for two groups that may differ in mortality as well as in health, then the life table (the A t ) must be estimated from the available data. If the data set is smaller than that used here (about 5700 persons, 40 000 transition pairs, and 1800 deaths), it is likely non-conservative to assume that variability of the life table is negligible. Then it would be safest to assess the variability via bootstrap, although the estimates derived here may be useful for preliminary calculations.
Limitations
These examples used data from the CHS for a particular definition of 'Healthy', but findings are likely to be similar for other data. We have not examined a system with more than three states in detail, but note that the prevalence in a 6-state system also converges to be independent of the initial conditions, similar to Figure 2 [6] . The surprisingly good performance of the Prev:Equil estimate relies on the probabilities changing slowly with age. It may not perform as well in situations where that is not the case. The small number of imputed transitions (2 per cent) might have slightly affected the variability of the estimates.
CONCLUSION
Estimating the age-specific population prevalence directly from the transition probabilities may be useful in some situations, although in the example the resulting estimate had a larger mean square error than conventional estimates. Applying the Sullivan method to Prev:Equil yielded a good estimate of YHL without requiring the calculation of the MSLT. In some situations, the standard error of YHL was appropriate, and could be used to compare groups of interest. These results need to be replicated with data from different populations.
APPENDIX A: DERIVATION OF K , THE 'EQUILIBRIUM' RATIO OF HEALTHY TO SICK Let H t , H t+1 be the number of Healthy persons at times t and t +1. Let S t , S t+1 be the number of Sick persons at times t and t +1. If the transition probabilities are time homogeneous (do not change with age), we conjecture that the ratio of the number Healthy to the number Sick approaches a constant; that is, that there is a constant, K , such that eventually, at some time t,
H t+1 and S t+1 can be calculated from H t and S t and the transition probabilities, as follows:
From equation (A1), H t = K * S t . Substituting for H t in equations (A2) and (A3) yields
From equation (A1), the ratio of equation (A4) to (A5)= K , S t cancels out, and Figure 1 , the ratio of Healthy to Sick will eventually be constant, in this case 2.67; that is, after a few years to overcome any imbalance caused by the initial conditions, there will always be approximately 2.67 times as many Healthy as Sick persons, until eventually all are dead. Prev:Equil will be 2.67/(1+2.67) = 0.73. In the special case where P(H |S) = 0 and P(H |H ) > P(S|S), K is twice the first term. There is thus an equilibrium prevalence even when persons cannot return to health after illness (P(H |S) = 0). If P(H |H ) < P(S|S), however, that prevalence is 0.
APPENDIX B: DERIVATION OF STANDARD ERROR FOR PREV:EQUIL USING THE DELTA METHOD
One-step transition probabilities are given in Table BI . In Table BI The variance approximation assumes that the transition probabilities are homogeneous within states. Although heterogeneity is almost surely the case, the close agreement of columns 5 and 6 in Table I suggests that the consequences of violating this assumption are small.
